Brief: BioInvent Q4 Sales SEK 21.4 Million
27/02/2025 07:00
Feb 27 (Reuters) - BioInvent Q4 adjusted EPS SEK -1.78. Q4 net income SEK -116.9 million Q4 adjusted free cash flow SEK -98.3 million
BINV — BioInvent International AB News Story
0.000.00%
Last trade - 00:00- SEK1.59bn
- SEK1.14bn
- SEK226.50m